NewsAI-assisted

Jagsonpal Pharmaceuticals Boosts Portfolio With Strategic Yash Pharma Acquisition

Jagsonpal acquires Yash Pharma, expanding into dermatology and pediatrics, enhancing market position.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Jun 28, 2024Updated Jun 26, 2025 · 2 min read
Share
Jagsonpal Pharmaceuticals Boosts Portfolio With Strategic Yash Pharma Acquisition
https://blockchain.news/news/blockchain-infrastructure-firm-chain-completes-acquisition-of-mdt-for-100m
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

Jagsonpal Pharmaceuticals has announced the acquisition of Yash Pharma's businesses in India and Bhutan, facilitated by boutique investment banking firm Growthally Advisors. This strategic move not only expands Jagsonpal's therapeutic footprint but also strengthens its market position significantly.

The merger is particularly noteworthy as it brings together two companies with complementary strengths. With a 60-year legacy focused on gynaecology and orthopaedics, Jagsonpal Pharmaceuticals now integrates Yash Pharma's extensive portfolio of 33 dermatology and paediatrics brands. This expansion not only diversifies Jagsonpal's product range but also marks its entry into a new market segment valued at Rs 20,000 crore (Source: IQVIA), promising substantial growth prospects.

Investor presentation of Jagsonpal stated, “This acquisition is the perfect recipe for Jagsonpal. Yash Pharma’s strengths in dermatology and pediatrics can now be leveraged to align with our long-term growth objectives. Now, with our portfolio getting extended with this access to new customer segments, the company is poised to significantly strengthen our market position.”

Growthally Advisors Pvt. Ltd., a specialized boutique investment banking firm well-versed in the nuances of the Indian Pharmaceutical and Healthcare sectors, successfully guided this intricate transaction. Leveraging their deep expertise in mergers and acquisitions, they seamlessly aligned their vision of fostering sustainable and profitable long-term growth with Jagsonpal’s strategic objectives.

“We are proud to have been facilitators of this mutually rewarding partnership. We have always been helping emerging corporates in an Indian Pharmaceuticals and healthcare industry in unlocking their long-term objectives through innovative solutions that optimise their growth trajectory. We believe that this transaction is a perfect example of how strategic acquisitions can ensure benefits for all stakeholders”, stated Bhupinder Garg, Managing Director of Growthally Advisors.

 

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →